Literature DB >> 9840305

Anastomotic recurrence of oesophageal squamous cell carcinoma after transthoracic oesophagectomy.

H Kato1, Y Tachimori, H Watanabe, H Yamaguchi, T Ishikawa, Y Nakanishi, A Ochiai.   

Abstract

OBJECTIVE: To assess the incidence of anastomotic recurrence of oesophageal carcinoma and its relationship with proximal surgical margin invaded by tumour.
DESIGN: Retrospective study.
SETTING: National Cancer Center, Tokyo.
SUBJECTS: 463 patients with thoracic oesophageal squamous carcinoma who underwent transthoracic oesophagectomy with a minimal follow-up of three years. MAIN OUTCOME MEASURES: Proximal surgical margin, anastomotic recurrence rate, prognosis.
RESULTS: Anastomotic recurrence developed in 12 of the 463 patients (3%), 10 of whom had histologically clear surgical margins. Sixteen patients had histologically invaded surgical margins, 13 of whom developed recurrent disease, 2 (13%) at the anastomosis. These 2 patients died of other diseases after treatment for their recurrent tumours. Two patients with anastomotic recurrence lived for over 5 years without signs of disease after excision of the recurrent tumour. Necropsy of 47 patients with recurrent tumors showed that only one (2%) was at the anastomosis.
CONCLUSIONS: Anastomotic recurrence was not inevitable and was rarely fatal in patients with invaded proximal surgical margins at transthoracic oesophagectomy. However, although infrequent, it did occur, even in patients with a cancer-free surgical margin. Resection may be indicated for patients with anastomotic recurrence and no other signs of metastases.

Entities:  

Mesh:

Year:  1998        PMID: 9840305     DOI: 10.1080/110241598750005390

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  6 in total

1.  Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection.

Authors:  Po-Kuei Hsu; Bing-Yen Wang; Chien-Sheng Huang; Yu-Chung Wu; Wen-Hu Hsu
Journal:  J Gastrointest Surg       Date:  2011-02-15       Impact factor: 3.452

2.  Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.

Authors:  Andrew P Barbour; Nabil P Rizk; Mithat Gonen; Laura Tang; Manjit S Bains; Valerie W Rusch; Daniel G Coit; Murray F Brennan
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

3.  Role of postoperative radiotherapy for microscopic margin involvement in the squamous cell carcinoma of esophagus.

Authors:  Sanghyuk Song; Eui Kyu Chie; Hak Jae Kim; Chang-Hyun Kang; Young Tae Kim; Joo Hyun Kim; Charn Il Park
Journal:  Cancer Res Treat       Date:  2013-09-30       Impact factor: 4.679

4.  Postoperative lymphatic recurrence distribution and delineation of the radiation field in lower thoracic squamous cell esophageal carcinomas: a real-world study.

Authors:  Rongxu Du; Songqing Fan; Shuchai Zhu; Jie Li; Anhui Shi; Xiaobin Wang; Xia Hou; Cheng Zeng; Dan Guo; Rongrong Tian; Dan Yang; Leilei Jiang; Xin Dong; Rong Yu; Huiming Yu; Dongming Li
Journal:  Radiat Oncol       Date:  2022-03-05       Impact factor: 3.481

5.  Postoperative extended-volume external-beam radiation therapy in high-risk esophageal cancer patients: a prospective experience.

Authors:  E Yu; P Tai; J Younus; R Malthaner; P Truong; L Stitt; G Rodrigues; R Ash; R Dar; B Yaremko; A Tomiak; B Dingle; M Sanatani; M Vincent; W Kocha; D Fortin; R Inculet
Journal:  Curr Oncol       Date:  2009-08       Impact factor: 3.677

6.  High dose rate brachytherapy (HDR-BT) in locally advanced oesophageal cancer. Clinic response and survival related to biological equivalent dose (BED).

Authors:  Maria C López Carrizosa; P Maria Samper Ots; A Rodríguez Pérez; A Sotoca; J Sáez Garrido; M M de Miguel
Journal:  Clin Transl Oncol       Date:  2007-06       Impact factor: 3.340

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.